Gene · 10462
CLEC10A: C-type lectin domain containing 10A
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CLEC10A: C-type lectin domain containing 10A. Genes, record 10462. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/10462
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q8IUN9 | C-type lectin domain family 10 member A | 316 | 4 | Ensembl, GeneID, HGNC |
Source UniProt
Patents24
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 42461 | Q8IUN9 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 997 | Q8IUN9 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 997 | Q8IUN9 | Espacenet |
| JP 2025520377 A | 2025-07-03 | 164 | Q8IUN9 | Espacenet |
| JP 2025520384 A | 2025-07-03 | 85 | Q8IUN9 | Espacenet |
| JP 2025520404 A | 2025-07-03 | 58 | Q8IUN9 | Espacenet |
| EP 4536271 A2 | 2025-04-16 | 164 | Q8IUN9 | Espacenet |
| EP 4536281 A2 | 2025-04-16 | 58 | Q8IUN9 | Espacenet |
| EP 4536282 A2 | 2025-04-16 | 85 | Q8IUN9 | Espacenet |
| US 11459389 B2 | 2022-10-04 | 348 | Q8IUN9 | Espacenet |
1 to 10 of 24
See all 24 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,344
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CLEC10A papers | Newest fiscal year |
|---|---|---|---|
| P30AI027763 | UCSF-Bay Area Center for AIDS Research | 9 | 2025 |
| ZIANS003130 | Neuropathogenesis of Retroviral Infections | 8 | 2025 |
| P30ES017885 | Michigan Center on Lifestage Environmental Exposures and Disease (M-LEEaD) | 7 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 6 | 2025 |
| P51OD011092 | Support for National Primate Research Center | 6 | 2025 |
| P30CA016042 | Cancer Center Support Grant | 5 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 4 | 2025 |
| R01AI022553 | Molecular Analysis of Host Immune Response in Leprosy | 4 | 2025 |
| R01AR040312 | CD1-restricted T-cell Responses in Skin | 4 | 2025 |
| R24AI067039 | CFAR Network of Integrated Clinical Systems (CNICS) | 4 | 2025 |
1 to 10 of 1,344Source NIH's project files
See all 1,344 nih grantsPapers1,864
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Remote Ischemic Post-Conditioning Preserves the Neurovascular Unit by Brain-Derived Gas6 That Drives Monocyte-Derived Macrophage Reprogramming via Axl and Vimentin after SAH. | Adv Sci (Weinh) | 2026 | 42801717 | PubTator, text mining | PubMed |
| Glycovariants of CA-125 in the early detection of ovarian cancer. | medRxiv | 2026 | 42779812 | PubTator, text mining | PubMed |
| Reversible Modulation of Glycan Recognition in C-Type Lectins by Calcium/Lanthanide Exchange. | Chembiochem | 2026 | 42764681 | PubTator, text mining | PubMed |
| Druggable secondary sites in C-type lectin-like domains: Mechanistic insights and opportunities for chemical modulation. | Curr Opin Chem Biol | 2026 | 42759193 | PubTator, text mining | PubMed |
| Candidate biomarkers in narcolepsy in H1N1-vaccinated cohorts: A proteomic and transcriptomic study. | Sleep Med | 2026 | 42748496 | PubTator, text mining | PubMed |
| CLR-Seq: A pipeline to identify bacterial microbiota species with immune-relevant glycan moieties through human C-type lectin receptor interaction. | PLoS One | 2026 | 42594336 | PubTator, text mining | PubMed |
| Identification of an Immunotherapy-Associated CD1c+CLEC10A+ Dendritic Cell Subset and Development of a Prognostic Model in Breast Cancer. | Int J Womens Health | 2026 | 42436936 | PubTator, text mining | PubMed |
| Identification and Prognostic Analysis of Immune-Related Genes Co-Regulated by Key Histone Modifications in Breast Cancer. | Curr Issues Mol Biol | 2026 | 42353587 | PubTator, text mining | PubMed |
| Cancer-associated alterations in O-GalNAc glycosylation. | Glycobiology | 2026 | 42340347 | PubTator, text mining | PubMed |
| Bioinformatic identification of CD8+ T cell activation mediated by key genes in fecal microbiota transplantation for irritable bowel syndrome. | PLoS One | 2026 | 42302008 | PubTator, text mining | PubMed |
1 to 10 of 1,864
See all 1,864 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/10462
GET https://conductscience.org/api/genes/v1/10462/patents?page=2